Literature DB >> 21497514

Unique ties between hepatitis C virus replication and intracellular lipids.

Eva Herker1, Melanie Ott.   

Abstract

Hepatitis C virus (HCV) infects approximately 3% of the world's population, establishing a lifelong infection in the majority of cases. The life cycle of HCV is closely tied to the lipid metabolism of liver cells, and lipid droplets have emerged as crucial intracellular organelles that support persistent propagation of viral infection. In this review, we examine recent advances in our understanding of how HCV usurps intracellular lipids to propagate, and highlight unique opportunities for therapeutic intervention.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21497514      PMCID: PMC3118981          DOI: 10.1016/j.tem.2011.03.004

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  82 in total

1.  Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment.

Authors:  Karl-Dimiter Bissig; Stefan F Wieland; Phu Tran; Masanori Isogawa; Tam T Le; Francis V Chisari; Inder M Verma
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

2.  Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture.

Authors:  Pablo Gastaminza; Kelly A Dryden; Bryan Boyd; Malcolm R Wood; Mansun Law; Mark Yeager; Francis V Chisari
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

3.  Ultrastructural and quantitative analysis of the lipid droplet clustering induced by hepatitis C virus core protein.

Authors:  Marion Depla; Rustem Uzbekov; Christophe Hourioux; Emmanuelle Blanchard; Amélie Le Gouge; Ludovic Gillet; Philippe Roingeard
Journal:  Cell Mol Life Sci       Date:  2010-04-27       Impact factor: 9.261

4.  Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy.

Authors:  Stephen A Harrison; Lorenzo Rossaro; Ke-Qin Hu; Keyur Patel; Hans Tillmann; Sandeep Dhaliwal; Dawn M Torres; Kenneth Koury; Venkata S Goteti; Stephanie Noviello; Clifford A Brass; Janice K Albrecht; John G McHutchison; Mark S Sulkowski
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

5.  Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes.

Authors:  Philippe Podevin; Arnaud Carpentier; Véronique Pène; Lynda Aoudjehane; Matthieu Carrière; Sakina Zaïdi; Céline Hernandez; Vanessa Calle; Jean-François Méritet; Olivier Scatton; Marlène Dreux; François-Loïc Cosset; Takaji Wakita; Ralf Bartenschlager; Sylvie Demignot; Filoména Conti; Arielle R Rosenberg; Yvon Calmus
Journal:  Gastroenterology       Date:  2010-07-01       Impact factor: 22.682

6.  Lipoprotein lipase and hepatic triglyceride lipase reduce the infectivity of hepatitis C virus (HCV) through their catalytic activities on HCV-associated lipoproteins.

Authors:  Yuko Shimizu; Takayuki Hishiki; Kazuo Sugiyama; Kazuya Ogawa; Kenji Funami; Atsushi Kato; Yuki Ohsaki; Toyoshi Fujimoto; Hiroshi Takaku; Kunitada Shimotohno
Journal:  Virology       Date:  2010-09-06       Impact factor: 3.616

7.  Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms.

Authors:  Takayuki Hishiki; Yuko Shimizu; Reiri Tobita; Kazuo Sugiyama; Kazuya Ogawa; Kenji Funami; Yuki Ohsaki; Toyoshi Fujimoto; Hiroshi Takaku; Takaji Wakita; Thomas F Baumert; Yusuke Miyanari; Kunitada Shimotohno
Journal:  J Virol       Date:  2010-09-08       Impact factor: 5.103

8.  The C-terminal alpha-helix domain of apolipoprotein E is required for interaction with nonstructural protein 5A and assembly of hepatitis C virus.

Authors:  Wei Cun; Jieyun Jiang; Guangxiang Luo
Journal:  J Virol       Date:  2010-08-18       Impact factor: 5.103

9.  Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures.

Authors:  Alexander Ploss; Salman R Khetani; Christopher T Jones; Andrew J Syder; Kartik Trehan; Valeriya A Gaysinskaya; Kathy Mu; Kimberly Ritola; Charles M Rice; Sangeeta N Bhatia
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

10.  Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system.

Authors:  Christopher T Jones; Maria Teresa Catanese; Lok Man J Law; Salman R Khetani; Andrew J Syder; Alexander Ploss; Thomas S Oh; John W Schoggins; Margaret R MacDonald; Sangeeta N Bhatia; Charles M Rice
Journal:  Nat Biotechnol       Date:  2010-01-31       Impact factor: 54.908

View more
  56 in total

Review 1.  The dynamic roles of intracellular lipid droplets: from archaea to mammals.

Authors:  Denis J Murphy
Journal:  Protoplasma       Date:  2011-10-15       Impact factor: 3.356

2.  Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling.

Authors:  Autumn G York; Kevin J Williams; Joseph P Argus; Quan D Zhou; Gurpreet Brar; Laurent Vergnes; Elizabeth E Gray; Anjie Zhen; Nicholas C Wu; Douglas H Yamada; Cameron R Cunningham; Elizabeth J Tarling; Moses Q Wilks; David Casero; David H Gray; Amy K Yu; Eric S Wang; David G Brooks; Ren Sun; Scott G Kitchen; Ting-Ting Wu; Karen Reue; Daniel B Stetson; Steven J Bensinger
Journal:  Cell       Date:  2015-12-10       Impact factor: 41.582

3.  A thematic review series: lipid droplet storage and metabolism: from yeast to man.

Authors:  Karen Reue
Journal:  J Lipid Res       Date:  2011-09-15       Impact factor: 5.922

Review 4.  Lipids and RNA virus replication.

Authors:  Kouacou V Konan; Lorena Sanchez-Felipe
Journal:  Curr Opin Virol       Date:  2014-09-28       Impact factor: 7.090

Review 5.  Viral activation of cellular metabolism.

Authors:  Erica L Sanchez; Michael Lagunoff
Journal:  Virology       Date:  2015-03-23       Impact factor: 3.616

Review 6.  Expanding roles for lipid droplets.

Authors:  Michael A Welte
Journal:  Curr Biol       Date:  2015-06-01       Impact factor: 10.834

Review 7.  Hepatitis C Virus-Genotype 3: Update on Current and Emergent Therapeutic Interventions.

Authors:  Steven W Johnson; Dorothea K Thompson; Brianne Raccor
Journal:  Curr Infect Dis Rep       Date:  2017-06       Impact factor: 3.725

8.  Very-low-density lipoprotein (VLDL)-producing and hepatitis C virus-replicating HepG2 cells secrete no more lipoviroparticles than VLDL-deficient Huh7.5 cells.

Authors:  Baptiste Jammart; Maud Michelet; Eve-Isabelle Pécheur; Romain Parent; Birke Bartosch; Fabien Zoulim; David Durantel
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

9.  The lipid droplet-associated protein perilipin 3 facilitates hepatitis C virus-driven hepatic steatosis.

Authors:  Daniel Ferguson; Jun Zhang; Matthew A Davis; Robert N Helsley; Lise-Lotte Vedin; Richard G Lee; Rosanne M Crooke; Mark J Graham; Daniela S Allende; Paolo Parini; J Mark Brown
Journal:  J Lipid Res       Date:  2016-12-10       Impact factor: 5.922

10.  Hepatitis C virus NS4B targets lipid droplets through hydrophobic residues in the amphipathic helices.

Authors:  Torahiko Tanaka; Kazumichi Kuroda; Masanori Ikeda; Takaji Wakita; Nobuyuki Kato; Makoto Makishima
Journal:  J Lipid Res       Date:  2013-01-12       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.